title: Natural products to drugs: natural product derived compounds in clinical trials.
abstract: Natural product and natural product-derived compounds that are being evaluated in clinical trials or in registration (current 31 December 2004) have been reviewed. Natural product derived drugs launched in the United States of America, Europe and Japan since 1998 and new natural product templates discovered since 1990 are discussed.
authors.affiliation: MerLion Pharmaceuticals, 1 Science Park Road, The Capricorn #05-01, Singapore Science Park II, Singapore 117528. mark@merlionpharma.com
authors.forename: Mark S
authors.initials: MS
authors.lastname: Butler
mesh_terms: D001688:Biological Products / Q000737:chemistry*; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000639:trends*; D015394:Molecular Structure; D004364:Pharmaceutical Preparations / Q000737:chemistry*
chemical_list: D001688:Biological Products; D004364:Pharmaceutical Preparations